DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 139 filers reported holding DIPLOMAT PHARMACY INC in Q3 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $79,000 | -24.0% | 19,750 | -7.3% | 0.00% | -20.0% |
| Q3 2019 | $104,000 | -16.8% | 21,300 | +0.5% | 0.01% | -16.7% |
| Q2 2019 | $125,000 | +1.6% | 21,200 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $123,000 | -57.0% | 21,200 | -0.1% | 0.01% | -62.5% |
| Q4 2018 | $286,000 | -40.8% | 21,222 | -14.8% | 0.02% | -23.8% |
| Q3 2018 | $483,000 | -12.5% | 24,900 | +15.3% | 0.02% | -16.0% |
| Q2 2018 | $552,000 | +28.1% | 21,600 | +0.9% | 0.02% | +25.0% |
| Q1 2018 | $431,000 | +3.9% | 21,400 | +3.4% | 0.02% | +5.3% |
| Q4 2017 | $415,000 | +3.2% | 20,700 | +6.7% | 0.02% | 0.0% |
| Q3 2017 | $402,000 | +52.9% | 19,400 | +9.0% | 0.02% | +46.2% |
| Q2 2017 | $263,000 | -6.7% | 17,800 | +0.6% | 0.01% | -7.1% |
| Q1 2017 | $282,000 | +30.0% | 17,700 | +2.9% | 0.01% | +27.3% |
| Q4 2016 | $217,000 | -59.4% | 17,200 | -9.9% | 0.01% | -60.7% |
| Q3 2016 | $535,000 | -5.1% | 19,100 | +18.6% | 0.03% | -6.7% |
| Q2 2016 | $564,000 | +31.2% | 16,100 | +2.5% | 0.03% | +36.4% |
| Q1 2016 | $430,000 | – | 15,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|